Related Experiment Video
Updated: May 9, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
[Prognosis of patients with tuberculosis]
Nobuyuki Horita1, Naoki Miyazawa, Takashi Yoshiyama
1Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, 3-9, Fukuura, Kanazawa-ku, Yokohama-shi, Kanagawa 236-0004, Japan. nobuyuki_horita@yahoo.co.jp
Abstract:
The global incidence of tuberculosis peaked around the year 2003 and is currently declining gradually. However, the worldwide incidence of new tuberculosis cases is still estimated to be 8.8 million/year, with 1.5 million deaths occurring per year. Considering that previous studies have determined the risk factors for death due to tuberculosis, we aimed at reviewing the literature to collectively evaluate these risk factors. According our literature review of 12 articles published in English language and 7 articles published in Japanese, the risk factors for death due to tuberculosis are age, human immunodeficiency virus (HIV) co-infection, multi-drug resistant tuberculosis (MDR-TB), malnutrition, low activities of daily living, co-morbidities, unemployment, and drug injection. We developed a scoring system to calculate the Tuberculosis Prognostic Score using 4 risk factors, namely, age, serum albumin level, oxygen requirement, and activities of daily living, after assessing several cohorts in Japan, in which HIV co-infection and MDR-TB are rare and their associations with mortality due to tuberculosis patients are unclear. This scoring system was successfully able to estimate life prognosis of inpatients with newly diagnosed, smear-positive, lung tuberculosis without MDR-TB and/or HIV virus co-infection.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: